In various mouse models of PD, GLP-1 mimetics have shown efficacy in reducing chronic neuronal inflammation, dopaminergic neuron loss, oxidative stress, and α-synuclein levels, ultimately leading to improved motor coordination [23,34]. Here, GLP1R is linked to Parkinson disease.